Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.

Sunil BhandariSamir MehtaArif KhwajaJohn G F ClelandNatalie IvesElizabeth BrettellMarie ValentePaul Cockwellnull null

Published in: The New England journal of medicine (2022)

Among patients with advanced and progressive chronic kidney disease, the discontinuation of RAS inhibitors was not associated with a significant between-group difference in the long-term rate of decrease in the eGFR. (Funded by the National Institute for Health Research and the Medical Research Council; STOP ACEi EudraCT number, 2013-003798-82; ISRCTN number, 62869767.).

Keyphrases

chronic kidney disease
end stage renal disease
small cell lung cancer
multiple sclerosis
healthcare
epidermal growth factor receptor
tyrosine kinase
peritoneal dialysis
quality improvement